Current Clinical Trials

Pediatrics hematology/oncology current clinical trials research

To inquire about pediatric hematology oncology ongoing clinical trials, please reach the clinical research team on 01-350000 Ext: 5514

For trials involving Dr. Abboud please reach Ext: 5514

For international clinical trials on malignant hematology or blood cancers, please check the following link: https://clinicaltrials.gov/

Ongoing pediatrics hematology oncology clinical research projects:

• ​A Phase 3 Double-blind, Randomized, Placebo-controlled, Multicenter Study of GBT440 Administered Orally to Patients With Sickle Cell Disease
•  A Multi-Centre, Phase II, Randomized, Double-Blind, Placebo- Controlled Study to Investigate Efficacy and Safety of Sevuparin Infusion for the Management of Acute Vaso-Occlusive Crisis (VOC) in Subjects with Sickle-Cell Disease (SCD)
•  A Phase 2a, Open-label, Single and Multiple Dose Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Exploratory Treatment Effect of GBT440 in Adolescents with Sickle Cell Disease
• A phase 3, Open-label, Randomized, Multicenter, Controled trial to evaluate the Pharmacokinetics and Pharmacodynamcis of Edoxaban with standard of care Anticoagulant therapy in Pediatric subjects from birth to less than 18 years of age with confirmed venous Thromboembolism (VTE).